Protein Expression Core
蛋白质表达核心
基本信息
- 批准号:7706297
- 负责人:
- 金额:$ 30.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-03-01 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAntibodiesAntigensAreaBiological AssayDevelopmentDiagnosticEmergency SituationGoalsHandInvestigationMolecular GeneticsPilot ProjectsProductionProtein BiochemistryProtein FragmentProteinsQuality ControlRecombinant ProteinsResearch PersonnelScientistServicesStandards of Weights and MeasuresSystemTherapeuticTimeTranslationsVaccinesWorkdesignexpression vectornovel vaccinesprotein expressionvaccine developmentvector
项目摘要
The Protein Expression Core will draw on the significant strengths of the Wadsworth Center in the areas of
molecular genetics and protein biochemistry. The goal of the Protein Production Core will be to facilitate the
investigative, developmental, and pilot studies proposed in various themes of this application. The staff of
the Core will assist investigators in the translation of their studies to quality controlled standard assays,
vaccines or therapeutics. Staff of the Protein Expression Core will work with investigators to develop
expression systems for the antigens required for their studies either using commercial vectors or customized
expression vectors. The facility will provide a complete protein expression and purification service. The staff
of the Protein Production Core will produce highly purified standardized lots of recombinant protein antigens,
recombinant proteins or protein fragments, purified antibodies and modified proteins as needed by the
investigators for the development of multiplex diagnostic assays and novel vaccines. In the case of vaccine
development, the Core will provide proteins with low bacterial component contamination suitable for use in
animal studies. The Core is designed to provide both advisory and hands on support to scientists, who need
larger amounts of purified recombinant proteins for their investigations. A goal of the Core will be to prepare
stable stocks of proteins and expression strains so that in a time of emergency production of these materials
will be rapid.
蛋白质表达核心将利用沃兹沃斯中心在以下领域的显著优势:
分子遗传学和蛋白质生物化学。蛋白质生产核心的目标是促进
在本申请的各种主题中提出的调查、开发和试点研究。工作人员
核心将协助研究者将他们的研究转化为质量控制的标准测定,
疫苗或治疗剂。蛋白表达核心的工作人员将与研究人员合作,
使用商业载体或定制的用于其研究所需抗原的表达系统
表达载体。该设施将提供完整的蛋白质表达和纯化服务。工作人员
蛋白质生产核心将生产高度纯化的标准化批次的重组蛋白抗原,
重组蛋白或蛋白片段、纯化的抗体和修饰的蛋白,
研究人员开发了多重诊断分析和新型疫苗。在疫苗方面,
开发,核心将提供低细菌成分污染的蛋白质,适用于
动物研究。该核心旨在为科学家提供咨询和实际支持,他们需要
大量纯化的重组蛋白用于他们的研究。核心的一个目标是准备
蛋白质和表达菌株的稳定储备,以便在紧急生产这些材料的时候
会很快。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARLENE BELFORT其他文献
MARLENE BELFORT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARLENE BELFORT', 18)}}的其他基金
RNA Science and Technology in Health and Disease
RNA科学与技术在健康和疾病中的应用
- 批准号:
10670064 - 财政年份:2019
- 资助金额:
$ 30.11万 - 项目类别:
RNA Science and Technology in Health and Disease
RNA科学与技术在健康和疾病中的应用
- 批准号:
10426167 - 财政年份:2019
- 资助金额:
$ 30.11万 - 项目类别:
RNA Science and Technology in Health and Disease
RNA科学与技术在健康和疾病中的应用
- 批准号:
10189657 - 财政年份:2019
- 资助金额:
$ 30.11万 - 项目类别:
Training in Biodefense and Emerging Infectious Disease
生物防御和新发传染病培训
- 批准号:
6910747 - 财政年份:2004
- 资助金额:
$ 30.11万 - 项目类别:
Training in Biodefense and Emerging Infectious Disease
生物防御和新发传染病培训
- 批准号:
6801334 - 财政年份:2004
- 资助金额:
$ 30.11万 - 项目类别:
NUCLEIC ACIDS--GORDON RESEARCH CONFERENCE 2000
核酸--戈登研究会议 2000
- 批准号:
6159402 - 财政年份:2000
- 资助金额:
$ 30.11万 - 项目类别:
相似海外基金
Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
- 批准号:
10574738 - 财政年份:2023
- 资助金额:
$ 30.11万 - 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
- 批准号:
10392870 - 财政年份:2021
- 资助金额:
$ 30.11万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
10092930 - 财政年份:2020
- 资助金额:
$ 30.11万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
9896170 - 财政年份:2020
- 资助金额:
$ 30.11万 - 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
- 批准号:
433456 - 财政年份:2020
- 资助金额:
$ 30.11万 - 项目类别:
Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
- 批准号:
19K15765 - 财政年份:2019
- 资助金额:
$ 30.11万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
- 批准号:
9932769 - 财政年份:2018
- 资助金额:
$ 30.11万 - 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
BB/P504713/1 - 财政年份:2017
- 资助金额:
$ 30.11万 - 项目类别:
Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
1932904 - 财政年份:2017
- 资助金额:
$ 30.11万 - 项目类别:
Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
- 批准号:
1632399 - 财政年份:2016
- 资助金额:
$ 30.11万 - 项目类别:
Standard Grant














{{item.name}}会员




